Literature DB >> 11600836

A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia.

A R Miserez1, P Y Muller, L Barella, M Schwietert, P Erb, P L Vernazza, M Battegay.   

Abstract

A single-nucleotide polymorphism (3'322C/G) was identified in the gene encoding a key cholesterol/triglyceride regulator, sterol-regulatory element-binding protein 1c (SREBP-1c). Although it did not alter the amino acid sequence, SREBP-1c-3'322C/G was predictive of highly active antiretroviral therapy-related hyperlipoproteinaemia. Increases in cholesterol were less frequently associated with homozygous SREBP-1c-3'322G (genotype 22) than with heterozygous/homozygous SREBP-1c-3'322C (genotypes 11/12) and correlated with leptin and insulin increases, particularly in genotype 11/12 carriers. A functional mutation linked to SREBP-1c-3'322C/G or messenger RNA conformation differences may explain our findings.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600836     DOI: 10.1097/00002030-200110190-00020

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

Review 1.  Human genetic polymorphisms affecting HIV-1 diseases.

Authors:  Tatsuo Shioda; Emi E Nakayama
Journal:  Int J Hematol       Date:  2006-07       Impact factor: 2.490

2.  Apolipoprotein E polymorphism and clinical course in childhood nephrotic syndrome.

Authors:  Sung-Do Kim; Il-Soo Kim; Byung-Cheol Lee; Kang-Duk Choi; Joo-Ho Chung; Chun-Gyoo Ihm; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2003-02-13       Impact factor: 3.714

3.  Human immunodeficiency virus genotype and hypertriglyceridemia.

Authors:  Soni J Anderson; John F Bradley; Andrea Ferreira-Gonzalez; Carleton T Garrett
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

4.  Genotype of bovine sterol regulatory element binding protein-1 (SREBP-1) is associated with fatty acid composition in Japanese Black cattle.

Authors:  Shogo Hoashi; Nobuhisa Ashida; Hideki Ohsaki; Takeshi Utsugi; Shinji Sasazaki; Masaaki Taniguchi; Kenji Oyama; Fumio Mukai; Hideyuki Mannen
Journal:  Mamm Genome       Date:  2007-12-01       Impact factor: 2.957

5.  Role of SREBP2 gene polymorphism on knee osteoarthritis in the South Indian Hyderabad Population: A hospital based study with G595C variant.

Authors:  Subhadra Poornima; Krishna Subramanyam; Imran Ali Khan; Sumanlatha G; Qurratulain Hasan
Journal:  J Orthop       Date:  2019-05-07

6.  Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.

Authors:  Gerard Aragonès; Carlos Alonso-Villaverde; Pedro Pardo-Reche; Anna Rull; Raúl Beltrán-Debón; Esther Rodríguez-Gallego; Laura Fernández-Sender; Jordi Camps; Jorge Joven
Journal:  BMC Med Genet       Date:  2011-09-22       Impact factor: 2.103

7.  Central role of SREBP-2 in the pathogenesis of osteoarthritis.

Authors:  Fotini Kostopoulou; Vasiliki Gkretsi; Konstantinos N Malizos; Dimitrios Iliopoulos; Pagona Oikonomou; Lazaros Poultsides; Aspasia Tsezou
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 8.  Antiretroviral therapy and dyslipidaemia: unlocking the code.

Authors:  Patrick W G Mallon
Journal:  PLoS Med       Date:  2006-01-24       Impact factor: 11.069

9.  Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.

Authors:  Andrea S Foulkes; David A Wohl; Ian Frank; Elaine Puleo; Stephanie Restine; Megan L Wolfe; Michael P Dube; Pablo Tebas; Muredach P Reilly
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

10.  Hypercholesterolemia is associated with the apolipoprotein C-III (APOC3) genotype in children receiving HAART: an eight-year retrospective study.

Authors:  Carlos A Rocco; Debora Mecikovsky; Paula Aulicino; Rosa Bologna; Luisa Sen; Andrea Mangano
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.